GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt
· Delayed Price · Currency is EGP 41.18
+0.76 (1.88%)
At close: Jun 4, 2025
GlaxoSmithKline S.A.E Market Cap
GlaxoSmithKline S.A.E has a market cap or net worth of 3.44 billion as of June 6, 2025. Its market cap has increased by 31.15% in one year.
Market Cap
3.44B
Enterprise Value
3.30B
Revenue
3.27B
Ranking
n/a
PE Ratio
14.21
Stock Price
41.18
Market Cap Chart
Since August 23, 2005, GlaxoSmithKline S.A.E's market cap has increased from 569.45M to 3.44B, an increase of 503.93%. That is a compound annual growth rate of 9.51%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Commercial International Bank Egypt (CIB) S.A.E. | 246.50B |
| El Sewedy Electric Company | 171.38B |
| Talaat Moustafa Group Holding | 117.40B |
| Eastern Company S.A.E | 96.51B |
| Misr Fertilizer Production Company | 78.43B |
| Alexandria Container&Cargo Handling Company | 67.81B |
| Egypt Aluminum | 67.32B |
| Telecom Egypt Company | 64.02B |